about
Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaReactivating NK Cells in Treating Refractory Head and Neck CancerA Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsNivolumab and Ipilimumab in Treating Patients With Rare TumorsEpstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaA Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsTGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPCDonafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal CarcinomaHigh-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal CancerEBV-TCR-T(YT-E001)for Patients With EBV-positive Recurrent or Metastatic NPCPhase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
P1050
Nasopharyngeal carcinomaRadiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its managementNimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial originSolitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literatureRadiation-induced temporo-mandibular joint disorder in post-radiotherapy nasopharyngeal carcinoma patients: assessment and treatmentDiagnostic Value of Magnetic Resonance Spectroscopy in Radiation Encephalopathy Induced by Radiotherapy for Patients with Nasopharyngeal Carcinoma: A Meta-AnalysisA Review: Proteomics in Nasopharyngeal CarcinomaUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsCurrent treatment options for local residual nasopharyngeal carcinomaThe criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationEmerging treatment options for nasopharyngeal carcinomaPatterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidencePrognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysisOccipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature reviewOmics-based identification of biomarkers for nasopharyngeal carcinomaPretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.Serglycin in human cancersAncient migration routes of Austronesian-speaking populations in oceanic Southeast Asia and Melanesia might mimic the spread of nasopharyngeal carcinomaNasopharyngeal carcinoma in the Northeastern states of India.The prevalence and prevention of nasopharyngeal carcinoma in China.Epigenetic disruption of cell signaling in nasopharyngeal carcinoma.Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysisPartial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literatureMicroRNAs in nasopharyngeal carcinoma.Prevalence of EBV RNA in sinonasal and Waldeyer's ring lymphomasThe role of microRNAs in nasopharyngeal carcinoma.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancersGWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseasesState-of-the-art management of nasopharyngeal carcinoma: current and future directionsThe clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era?: a systematic review and meta-analysis of 7836 casesCyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma.Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients: A prisma-compliant meta-analysis.An endonasal approach to the resection of a papillary seromucinous adenocarcinoma of the eustacian tube.Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinomaBilateral myositis ossificans of the masseter muscle after chemoradiotherapy and critical illness neuropathy--report of a rare entity and review of literature.Radiation-induced osteosarcoma of the skull base after radiation therapy in a patient with nasopharyngeal carcinoma: a case report and review of the literature.An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
P921
Q58407479-BC2C5E73-CAEA-4041-BD07-A2EC73B98D7DQ58407645-277F3D3D-3BDA-4C36-979B-EF0BFA48B610Q58407690-67BB792D-00E8-41FC-8F67-78F94DD98B94Q58407717-11375C04-02FF-4B24-8068-A62AC0831BF3Q58407779-148FF40D-C550-4ED4-ACE5-512FAAB7F731Q58844425-015F58F0-A22F-4597-A323-57E900892508Q58844806-4180AE10-7AEF-41E7-8832-05A6F4C6657AQ58844991-989CDADB-EF1A-481E-A7F8-4B229BAE7F33Q58845492-D7F55753-23E7-4068-B6CA-F86D53AB8C6DQ58846004-C4E88A7C-781B-4432-AEDE-0059A3EC9CD0Q58847104-AFDB0447-72AD-4579-993D-9B3B3AB86E1DQ58849747-23DB7131-04A1-4E02-9A9E-26185011114E
P1050
Q21093175-36E78850-073B-4C74-9C64-F9ED5F901B8AQ24634976-D0736C1C-4804-4D13-9B2C-5D8180496A80Q24645217-B0472804-4AC4-4A41-8154-2F76EF48A79FQ26740041-8187770F-B7A2-4D27-B235-6D77D80E4275Q26746607-9D61ECC6-E91D-40A7-9F61-C5CB70CBA48CQ26767295-4A7FC21D-13B1-4F9A-B05B-FC1D90EEEB1AQ26800017-DDEDC41F-1F7E-4731-8F38-6FDC4FE371CDQ26823898-C92F992A-B45E-4429-AAF5-51DCA2037962Q26852207-8FE3C900-7E0A-4E4B-94A6-0A5AA660AB35Q26853527-6881C1B7-A92A-4EAE-A7A9-BB4AD3C6DC1AQ26995560-1DA718EB-16FC-4059-BE92-E3F5F6A14512Q27007474-5D302BBD-41B7-4348-A864-5178E85DAA90Q28077401-74F6D33F-B72B-4F81-B07B-C59A6BF1A4B6Q28078860-D5D426A9-1069-4ACB-9385-3BC9A4CD85DCQ28082480-76D4B3C6-99C3-4273-BB35-65E979263DE9Q30235263-BCD645C7-8C22-451C-9DA7-ED97606A53A4Q33346719-0CD0626F-4D4C-45F0-8842-4991D2F599F1Q33579353-4EF8E27A-0A1B-47B5-8F00-BE4CDDB2EEA7Q33579433-A4F698CA-91C4-41ED-BF36-6172A4B23386Q33579441-A4C03131-86E9-452E-B2CB-EEC5FCD135A0Q33579447-1072EAEF-2DC6-4A38-9F1E-79E714013388Q33579472-95786FB8-6B46-449F-9514-31BF8008594FQ33603685-37BB7C30-EA68-4362-924F-198B4746A56DQ33889391-134BA42C-172C-4C58-AF18-F5BBEFE59C56Q34517592-6582BA35-5276-47DC-9E30-5E6F59BF7688Q34572800-CC806888-72B7-433E-BDA7-D369892DFF2EQ34653351-E8B1D1AF-9519-4ABE-8A63-511381316066Q35043716-891B3530-CE98-449E-8536-5198F0BCDC9AQ35597559-3740AE7E-40EE-4D21-903C-3C8405FC2B5DQ36027817-E90F92B3-44DA-4D01-BF34-24DEC170EAEFQ36053844-8BA316B0-833B-4468-BA84-8186D1FEC5DCQ36065641-68185649-3FD6-4359-BC9D-9C8C51F79F33Q36152889-788E7D56-88E4-4EA8-8648-2B6E14FF7F07Q36310570-9B329681-A373-40F8-B309-0173E8216918Q36405314-98C14470-71D6-4297-A51F-A9F48F0C214BQ36834313-AED68064-7772-4B4E-874C-04BF4F4EA59EQ37183789-EC9ACEC4-54CF-4963-BCB1-B775CD80E50DQ37312714-941CAE9E-82DD-4EE1-9524-7E872773650FQ37465221-D1438856-ACD2-4131-8902-BB2D873FAB36Q37629085-4AD7BA76-4DB3-4914-9C72-307149CD2E35
P921
description
A neoplasm listed in Medical Subject Headings (MeSH)
@en
name
nasopharyngeal neoplasm
@en
tumeur du nasopharynx
@fr
type
label
nasopharyngeal neoplasm
@en
tumeur du nasopharynx
@fr
prefLabel
nasopharyngeal neoplasm
@en
tumeur du nasopharynx
@fr
P1995
P672
P486
P672
P31
P486
P672
C04.588.443.665.710.650
C07.550.350.650
C07.550.745.650
C09.647.710.650
C09.775.350.650
C09.775.549.650